The response to exogenous glucagon in hypoglycemic newborns, control newborns, and infants and children who had been primed with intravenously administered dextrose was evaluated. Dextrose (1 gm/kg) was injected rapidly, and, at 60 minutes, glucagon (0.03 to 0.3 mg/kg) was injected and blood glucose values measured every 15 minutes for one hour. In the infants and children, glucose values following the injection of glucagon rose 43 \ m=+-\ 3 mg/100 ml at 15 minutes and returned to preglucagon values (zero time) by 60 minutes. In both hypoglycemic and control newborns, glucose values following glucagon injection were lower after 15 minutes and continued to fall during the entire 60 minutes. The response to glucagon was significantly less (P<.001) at each time period in the newborn groups when compared to that in the infants and children.Gl ucagon is widely employed, diagnostically and therapeutically, for its ability to raise blood glucose levels.1·2 The hyperglycémie response to small doses of glucagon in newborn infants has been found to depend on the age of the infants and their expo¬ sure to labor prior to delivery.14 These differences were abolished when the dose of glucagon was in¬ creased tenfold (0.3 mg/kg). In tran¬ sient symptomatic neonatal hypoglycemia, the intravenous injection of glucagon (0.3 mg/kg) following subcutaneously injected epinephrine has resulted in little or no rise in the blood glucose level,5 thus implicating diminished liver glycogen stores as an important etiologic factor in the pathogenesis of this type of hypoglycemia.The purpose of the present study was to evaluate the response to gluca¬ gon in hypoglycémie newborns who had been primed with dextrose dur¬ ing an intravenous glucose tolerance test. The assumption was made that the dextrose load would prevent de¬ pletion of liver glycogen, thereby making it possible to study two dis¬ tinct mechanisms, glucose dis¬ appearance rate and glucagon re¬ sponse.
Methods and MaterialsSix newborns with symptomatic hypoglycemia, six control newborns, and six infants and children were included in the study. The mean age of the hypoglycémie newborns was 52 ± 13 (standard error of the mean) hours and of the controls 64 ± 24 hours (range, 5 hours to 7 days) at the time of testing. The infants and chil¬ dren ranged in age from 2 months to 6 years. Control newborns included infants who had minimal symptoms but were normoglycemic. Informed consent was ob¬ tained from the parents of the control group infants after the procedure had been carefully explained.Ten infants were born at term, and one pair of control twin infants was born at 32 weeks' gestation. The infants were pri¬ marily black, representative of the popu¬ lation of Cook County Hospital. There were four boys and two girls in the hy¬ poglycémie group, and the ratio was re¬ versed in the control newborns. Hypoglycemia was based on the presence of two blood glucose values of less than 20 mg/100 ml in the low-birthweight infants, less than 30 mg/100 ml in infants weighing more than 2,500 gm (5....